PLASMA LEVEL OF DES-ACYL GHRELIN PREDICTS DIGESTIVE SYMPTOMS IN PATIENTS UNDERGOING CHEMOTHERAPY FOR ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Miura, T. [1 ,3 ]
Mitsunaga, S. [1 ,2 ]
Matsumoto, N. [4 ]
Nakazato, M. [4 ]
Ohno, I. [1 ]
Shimizu, S. [1 ]
Takahashi, H. [1 ]
Okuyama, H. [1 ]
Kuwahara, A. [1 ]
Ikeda, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp E, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp E, Dept Palliat Care & Psychooncol, Kashiwa, Chiba, Japan
[4] Miyazaki Univ, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] Plasma des-acyl and acyl ghrelin in patients with eating disorders
    Uehara T.
    Omori I.
    Nakamura K.
    Suda M.
    Hosoda Y.
    Minegishi T.
    Mikuni M.
    Kangawa K.
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2005, 10 (4) : 264 - 266
  • [2] Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia
    Togawa, Koji
    Matsuzaki, Juntaro
    Kobayakawa, Masao
    Fukushima, Yasushi
    Suzaki, Fumio
    Kasugai, Kunio
    Nishizawa, Toshihiro
    Naito, Yuji
    Hayakawa, Toshihiko
    Kamiya, Takeshi
    Andoh, Takashi
    Yoshida, Hideo
    Tokura, Yoshifumi
    Nagata, Hiroshi
    Mori, Mikiji
    Kato, Kimihiko
    Hosoda, Hiroshi
    Takebayashi, Toru
    Miura, Soichiro
    Uemura, Naomi
    Joh, Takashi
    Hibi, Toshifumi
    Suzuki, Hidekazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 334 - 341
  • [3] Decreased ghrelin and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant epilepsy and maintained on the ketogenic diet
    Marchio, Maddalena
    Roli, Laura
    Giordano, Carmela
    Trenti, Tommaso
    Guerra, Azzurra
    Biagini, Giuseppe
    CLINICAL NUTRITION, 2019, 38 (02) : 954 - 957
  • [4] Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients
    Yano, Yuichiro
    Toshinai, Koji
    Inokuchi, Takashi
    Kangawa, Kenji
    Shimada, Kazuyuki
    Kario, Kazuomi
    Nakazato, Masamitsu
    ATHEROSCLEROSIS, 2009, 204 (02) : 590 - 594
  • [5] Plasma Des-acyl Ghrelin, but Not Plasma HMW Adiponectin, is a Useful Cardiometabolic Marker for Predicting Atherosclerosis in Elderly Hypertensive Patients
    Yano, Yuichiro
    Toshinai, Koji
    Inokuchi, Takashi
    Shimada, Kazuyuki
    Kario, Kazuomi
    Nakazato, Masamitsu
    CIRCULATION, 2009, 120 (18) : S1063 - S1063
  • [6] Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
    Muranaka, Hayato
    Hendifar, Andrew
    Osipov, Arsen
    Moshayedi, Natalie
    Placencio-Hickok, Veronica
    Tatonetti, Nicholas
    Stotland, Aleksandr
    Parker, Sarah
    Van Eyk, Jennifer
    Pandol, Stephen J.
    Bhowmick, Neil A.
    Gong, Jun
    CANCERS, 2023, 15 (11)
  • [7] Decrease of CA 19-9 in patients with advanced pancreatic cancer (APC) undergoing chemotherapy predicts survival time
    Pohlank, K.
    Hilbig, A.
    Pelzer, U.
    Stieler, J.
    Roll, L.
    Goerke, A.
    Sinn, M.
    Doerken, B.
    Riess, H.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer
    Ding, Honglu
    Yang, Qiuxia
    Mao, Yize
    Qin, Dailei
    Yao, Zehui
    Wang, Ruiqi
    Qin, Tao
    Li, Shengping
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1297 - 1310
  • [9] Goals of care designations in advanced pancreatic cancer patients undergoing palliative chemotherapy
    Anaka, Matthew
    Lee, Minji
    Lim, Elisa
    Ghosh, Sunita
    Cheung, Winson Y.
    Spratlin, Jennifer L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [10] Patient-reported symptoms from patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy.
    Wang, Xin Shelley
    Fogelman, David R.
    Shi, Qiuling
    Eng, Cathy
    Bokhari, Raza H.
    Huang, Furong
    Mobley, Gary M.
    Gilmore, Katherine R.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345